Adjuvants are essential components in vaccines that enhance and shape antigen-specific immune responses. Modern vaccines often use adjuvants to improve efficacy, especially for antigens with low immunogenicity. Adjuvants can reduce the required dose of vaccine antigens, increase global vaccine supply, and enhance immune responses. They can also broaden the antibody response, increase the magnitude and functionality of antibody responses, and enable more effective T cell responses. Adjuvants are classified into three main types: immunomodulatory molecules, combinations of immunomodulatory molecules and particulate formulations, and particulate formulations. Examples include aluminum salts, oil-in-water emulsions, virosomes, and TLR agonists. Adjuvants must be carefully selected to ensure safety, tolerability, and efficacy, and their mechanisms of action are still being studied. Adjuvants can influence antigen uptake, immune cell recruitment, and the activation of immune pathways such as the inflammasome. Adjuvant formulations must be optimized for different routes of administration and target populations. Adjuvants can also affect the immune response to different types of pathogens, such as intracellular pathogens requiring T cell responses. Adjuvants are crucial for developing next-generation vaccines against devastating infectious diseases. The development of adjuvants is ongoing, with a focus on understanding their mechanisms of action and improving their safety and efficacy. Adjuvants must be tested in preclinical models and clinical trials to ensure they are effective and safe. Adjuvants are important for vaccine development, especially for vaccines against diseases that lack effective vaccines. The future of adjuvant development includes targeting dendritic cells, improving mucosal immunity, and exploring alternative routes of administration. Adjuvants play a central role in vaccine development, and their selection and formulation are critical for the success of vaccines.Adjuvants are essential components in vaccines that enhance and shape antigen-specific immune responses. Modern vaccines often use adjuvants to improve efficacy, especially for antigens with low immunogenicity. Adjuvants can reduce the required dose of vaccine antigens, increase global vaccine supply, and enhance immune responses. They can also broaden the antibody response, increase the magnitude and functionality of antibody responses, and enable more effective T cell responses. Adjuvants are classified into three main types: immunomodulatory molecules, combinations of immunomodulatory molecules and particulate formulations, and particulate formulations. Examples include aluminum salts, oil-in-water emulsions, virosomes, and TLR agonists. Adjuvants must be carefully selected to ensure safety, tolerability, and efficacy, and their mechanisms of action are still being studied. Adjuvants can influence antigen uptake, immune cell recruitment, and the activation of immune pathways such as the inflammasome. Adjuvant formulations must be optimized for different routes of administration and target populations. Adjuvants can also affect the immune response to different types of pathogens, such as intracellular pathogens requiring T cell responses. Adjuvants are crucial for developing next-generation vaccines against devastating infectious diseases. The development of adjuvants is ongoing, with a focus on understanding their mechanisms of action and improving their safety and efficacy. Adjuvants must be tested in preclinical models and clinical trials to ensure they are effective and safe. Adjuvants are important for vaccine development, especially for vaccines against diseases that lack effective vaccines. The future of adjuvant development includes targeting dendritic cells, improving mucosal immunity, and exploring alternative routes of administration. Adjuvants play a central role in vaccine development, and their selection and formulation are critical for the success of vaccines.